JCR Pharmaceuticals Co., Ltd. (TYO:4552)

JCR Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, JCR Pharmaceuticals had annual revenue of 40.32B JPY with 21.91% growth. JCR Pharmaceuticals had revenue of 9.97B in the quarter ending March 31, 2026, with 38.57% growth.

• Revenue: 40.32B
• Revenue Growth: +21.91%
• P/S Ratio: 1.50
• Revenue / Employee: 40.85M
• Employees: 987
• Market Cap: 60.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	40.32B	7.25B	21.91%
Mar 31, 2025	33.07B	-9.80B	-22.86%
Mar 31, 2024	42.87B	8.53B	24.83%
Mar 31, 2023	34.34B	-16.74B	-32.77%
Mar 31, 2022	51.08B	21.00B	69.79%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error